ENFLONSIA
Active substance: clesrovimab
INJECTION, SOLUTION · CLESROVIMAB 150 mg/mL
United StatesActive
Marketing holder: Merck Sharp & Dohme LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- CLESROVIMAB · 150 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12093-6083-7f6b-9382-14d7228b3cc8;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0006-5073
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR
Sources
- product · openFDA NDC · 0006-5073 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0006-5073 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0006-5073 · Verified 2026-10-09 · open in source